Aspen Unscrambler™
Improve and optimize product quality, even at the molecular level.
Taking the Guesswork Out of Product Quality Analysis
Simplify the Complex
Faster Actionable Results
Secure, Compliant Project Workflows
PAT Portfolio Honored with a Pharma Manufacturing 2021 Innovation Award
The award celebrates technologies contributing to advancements in risk reduction, product quality improvement and manufacturing efficiency.
Related Products
Aspen Process Pulse™
Receive early and accurate warnings of product health issues to improve product quality, reduce waste and support PAT, in compliance with regulatory requirements.
Aspen ProMV®
Get early and accurate warnings on process health deviations with insights to prevent off-spec product, maintain efficiency and rapidly optimize operations.
Aspen Mtell®
Get early and accurate warning of when an asset failure will occur, how the failure will occur and what to do about it.
On Demand Webinar
Pharma companies continue to strive for tight control of critical quality attributes (CQAs). When Ferring Pharmaceuticals wanted to move from batch to continuous manufacturing, they found that laborat...
On-Demand Webinar
Pharmaceutical companies, CDMOs and CMOs face growing pressures to deliver more products at a lower cost while ensuring the quality and security of supply. Advanced PAT technologies address these chal...
White Paper
Pharmaceutical companies, CDMOs and CMOs continue to grapple with the tension between meeting the demand for increasingly diverse pharmaceutical products and the escalating challenges in ensuring supp...
Article
In this article from European Pharmaceutical Review, David Leitham, Senior Vice President and General Manager at AspenTech®, explains how implementing PAT pushes the industry towards Pharma 4.0. Downl...
On-Demand Webinar
Batch processing requires supremely accurate monitoring to ensure successful batch completion. In the case of deviations, the ability to prevent unwanted process behavior from happening is critical to...
On-Demand Webinar
If faced with inhomogeneous blends, manufacturers lose money and valuable time. Not to mention the possible risks of reblends and regulatory citations.
Case Study
GSK wanted to review the structure of its batch production record and associated workflows as part of a continuous improvement process. AspenTech was selected for this process due to integration with ...